Your browser is no longer supported. Please, upgrade your browser.
FENC [NASD]
Fennec Pharmaceuticals Inc.
Index- P/E- EPS (ttm)-0.62 Insider Own16.94% Shs Outstand26.01M Perf Week-6.20%
Market Cap120.68M Forward P/E- EPS next Y-0.66 Insider Trans0.00% Shs Float21.60M Perf Month4.28%
Income-16.20M PEG- EPS next Q0.75 Inst Own44.80% Short Float1.40% Perf Quarter-50.06%
Sales0.20M P/S603.41 EPS this Y-19.00% Inst Trans- Short Ratio1.94 Perf Half Y-33.28%
Book/sh0.73 P/B6.01 EPS next Y-364.00% ROA-57.00% Target Price10.80 Perf Year-46.20%
Cash/sh0.88 P/C4.97 EPS next 5Y- ROE-67.80% 52W Range3.82 - 10.08 Perf YTD-0.23%
Dividend- P/FCF- EPS past 5Y-65.90% ROI-61.50% 52W High-56.44% Beta0.04
Dividend %- Quick Ratio12.90 Sales past 5Y- Gross Margin- 52W Low14.86% ATR0.27
Employees9 Current Ratio12.90 Sales Q/Q- Oper. Margin- RSI (14)39.65 Volatility5.11% 6.29%
OptionableYes Debt/Eq0.26 EPS Q/Q33.60% Profit Margin- Rel Volume0.44 Prev Close4.64
ShortableYes LT Debt/Eq0.26 Earnings- Payout- Avg Volume155.97K Price4.39
Recom2.00 SMA20-2.20% SMA50-23.56% SMA200-37.77% Volume68,900 Change-5.39%
Jun-05-20Initiated Cantor Fitzgerald Overweight $18
Oct-11-18Initiated Goldman Buy
Dec-14-21 07:50PM  
Dec-13-21 10:08AM  
Dec-01-21 07:06AM  
Nov-30-21 04:20PM  
10:57AM  
06:00AM  
05:49AM  
Nov-29-21 07:23PM  
07:24AM  
06:00AM  
Nov-10-21 06:00AM  
Oct-05-21 08:30AM  
Sep-29-21 02:27PM  
Sep-09-21 06:00AM  
Aug-10-21 06:00AM  
Aug-02-21 03:18AM  
Jun-29-21 05:30PM  
Jun-24-21 06:00AM  
Jun-22-21 07:17AM  
06:00AM  
Jun-03-21 03:33AM  
May-28-21 06:00AM  
May-13-21 06:00AM  
Apr-04-21 05:54AM  
Mar-30-21 06:00AM  
Feb-03-21 01:59AM  
Dec-09-20 07:51AM  
Dec-02-20 11:27PM  
Nov-27-20 10:27AM  
Nov-19-20 10:02AM  
Nov-16-20 07:02AM  
Nov-05-20 07:46AM  
Nov-02-20 03:57PM  
02:30PM  
01:10PM  
11:29AM  
10:00AM  
09:15AM  
09:00AM  
08:00AM  
06:30AM  
12:15AM  
Nov-01-20 03:46PM  
Oct-30-20 09:00PM  
08:05PM  
06:45PM  
02:45PM  
12:00PM  
11:40AM  
11:01AM  
11:00AM  
09:35AM  
Oct-29-20 09:22PM  
07:55PM  
12:00PM  
11:30AM  
11:12AM  
11:00AM  
10:40AM  
09:38AM  
Oct-28-20 09:39PM  
08:00PM  
07:15PM  
02:27PM  
01:00PM  
01:00PM  
12:30PM  
11:45AM  
11:00AM  
10:20AM  
09:57AM  
Oct-27-20 12:00PM  
11:10AM  
11:00AM  
10:00AM  
09:57AM  
09:26AM  
Oct-26-20 05:24PM  
03:50PM  
12:55PM  
12:30PM  
11:45AM  
11:00AM  
11:00AM  
10:26AM  
Oct-23-20 07:10PM  
06:30PM  
04:55PM  
04:10PM  
10:40AM  
10:08AM  
Oct-22-20 05:25PM  
04:55PM  
10:45AM  
10:01AM  
Oct-21-20 02:30PM  
02:00PM  
01:55PM  
10:30AM  
10:00AM  
Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product PEDMARK, a formulation of Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
RALLIS CHRIS ADirectorOct 21Option Exercise1.503,3335,0003,333Oct 21 03:40 PM